| Cell culture ( is a major foundation of | | | | Yeast, Insect, and Mammal) and the |
| biopharmaceutical development, bioprocessing and | | | | biopharmaceutical product manufactured by these |
| manufacturing. As the biopharmaceutical market | | | | systems |
| grows, so should interest in the cell culture products | | | | Discussion of the preferences in media types vying |
| market. Biopharmaceutical products are developed | | | | for dominance in the market, including the following: |
| from large, complex protein molecules, which require | | | | ADCF - animal derived component free media |
| equally complex manufacturing methods and an array | | | | CD - chemically defined media |
| of analytical techniques. As growing cells for | | | | CSFM - complete serum free medium |
| biopharmaceutical production is slow, expensive and | | | | PF - protein free media |
| complicated, optimizing cell culture development is of | | | | SF - serum free media |
| paramount concern to companies developing | | | | SFM - serum free medium |
| biopharmaceuticals. | | | | Major Trends Impacting the Market stem cell |
| This report, Cell Culture represents the second time | | | | research (including plans of major companies)cell |
| that Kalorama has focused on culture used in the | | | | culture-based vaccine Production and generic |
| research and production of biopharmaceuticals, | | | | bipharmaceuticals |
| analyzing the world cell culture market and the major | | | | Profiles of 27 Leading Suppliers and information about |
| trends driving this market in three specific segments: | | | | M&A activities in recent years |
| Media, | | | | The information for this report was gathered using |
| Sera, and | | | | both primary and secondary research including |
| Reagents | | | | comprehensive research of secondary sources such |
| In addition to a thorough discussion of the | | | | as company literature, databases, investment |
| technologies and techniques currently employed and | | | | reports, and medical and business journals. Telephone |
| emerging in the cell culture area, the Kalorama's | | | | interviews and email correspondence were the |
| exhaustive report provides specific information on: | | | | primary method of gathering information. For the |
| Market Size, growth, and forecasts of the segments | | | | purpose of this study Kalorama Information |
| through 2013 | | | | conducted interviews with key industry officials, |
| Competitive Market Share by leading supplier as of | | | | consultants, and government personnel. These |
| 2008. | | | | sources were the primary basis in gathering |
| Estimated Market Share by Region (North America, | | | | information specifically relating to revenue and market |
| Europe, U.S.) | | | | share data presented in this report. Specific |
| Key Market Drivers and Restraints for suppliers, | | | | interviews with pharmaceutical company and cell |
| including discussions of biopharmaceutical pipelines, | | | | culture supply company representatives included |
| biomedical R&D directions, and the future of | | | | marketing directors, division managers, and product |
| transgenic plant and animal production. | | | | representatives. |
| Review of the various expression systems (Bacteria, | | | | |